Medicine
Varubi 90 mg tablet
Varubi 90 mg tablet is a prescription medicine containing Rolapitant for oral use, marketed by TerSera Therapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20ºC to 25ºC (68ºF to 77ºF), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Rolapitant
- Brand
- Varubi
- Strength
- 90 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 2 tablets
- Marketing authorisation holder
- TerSera Therapeutics
- Manufacturers
- TerSera TherapeuticsLuria Therapeutics
- Origin register
- US FDA, United States
- Storage
- Store at 20ºC to 25ºC (68ºF to 77ºF), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A04AD14 Rolapitant
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 October 2015
- Identifiers
- RxCUI 1665503, 1673373DailyMed set ID 8670c3cf-82d9-466d-be49-de33d8c8742b, a52896cd-4a98-49b8-82db-bf1985a64d97NDC 87628-101, 70720-101Application NDA206500
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2 tablet in 1 blister pack | 70720-101-02 | TerSera Therapeutics | 6 August 2019 |
| 2 tablet in 1 blister pack | 87628-101-02 | Luria Therapeutics | 8 September 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Rolapitant is a substance P/neurokinin-1 receptor antagonist. It is available as tablets for oral use. MedsAcross supplies Rolapitant for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about RolapitantFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Varubi prescribing information (Luria Therapeutics) · U.S. National Library of Medicine, DailyMed
Need Varubi 90 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.